Loraz and Juluca drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Juluca (dolutegravir sodium; rilpivirine hydrochloride). Common drug interactions include emotional distress among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Juluca. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Juluca?

Juluca has active ingredients of dolutegravir sodium; rilpivirine hydrochloride. eHealthMe is studying from 1,732 Juluca users. Check the latest studies of Juluca.



On Jul, 13, 2026

40 people who take Loraz and Juluca together, and have interactions are studied.

Loraz and Juluca drug interactions.

What are the common drug interactions of Loraz and Juluca, by gender? *:

female:

  1. Emotional distress
  2. Pain
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Osteoporosis (bones weak and more likely to break)
  5. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  6. Osteopenia (a condition where bone mineral density is lower than normal)
  7. Renal impairment (severely reduced kidney function)
  8. Chronic kidney disease
  9. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  10. Gout (uric acid crystals building up in the body)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Emotional distress
  3. Hyperkalaemia (damage to or disease of the kidney)
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Bone density decreased
  6. Renal impairment (severely reduced kidney function)
  7. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  8. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  9. Impaired work ability
  10. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)

What are the common drug interactions of Loraz and Juluca, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anaemia (lack of blood)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Emotional distress
  4. Gait disturbance
  5. Hyperkalaemia (damage to or disease of the kidney)
  6. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  7. Hypertension (high blood pressure)
  8. Pain
  9. Partner stress
  10. Renal failure (kidney dysfunction)

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Emotional distress
  3. Pain
  4. Renal failure (kidney dysfunction)
  5. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  6. Decreased activity
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Hyperkalaemia (damage to or disease of the kidney)
  9. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  10. Impaired work ability

50-59:

  1. Emotional distress
  2. Chronic kidney disease
  3. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  4. Gout (uric acid crystals building up in the body)
  5. Osteopenia (a condition where bone mineral density is lower than normal)
  6. Osteoporosis (bones weak and more likely to break)
  7. Alopecia (absence of hair from areas of the body)
  8. Asthenia (weakness)
  9. Bone disorder
  10. Bowel movement irregularity

60+:

  1. Renal disorder (kidney disease)

What are the existing conditions these people have? *

  1. Hiv Infection: 33 people, 82.50%
  2. High Blood Pressure: 13 people, 32.50%
  3. Pain: 9 people, 22.50%
  4. Erection Problems: 6 people, 15.00%
  5. High Blood Cholesterol: 6 people, 15.00%
  6. Depression: 6 people, 15.00%
  7. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 15.00%
  8. Hypersensitivity: 5 people, 12.50%
  9. Chronic Kidney Disease: 5 people, 12.50%
  10. Infection: 4 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Juluca?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Loraz and Juluca:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Juluca:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Loraz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Juluca and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam and dolutegravir sodium; rilpivirine hydrochloride (the active ingredients of Loraz and Juluca, respectively), and Loraz and Juluca (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: